Effect of ciprofloxacin on the pharmacokinetics and pharmacodynamics of warfarin

Clinical Infectious Diseases

Volumn 22, Issue 2, 1996, Pages 251-256

  Israel, Debra S ^b   Stotka, Jennifer ^b   Rock, William ^b   Sintek, Charles D ^b   Kamada, Alan K ^b   Klein, Catherine ^b   Swaim, William R ^b   Pluhar, Robert E ^b   Toscano, John P ^b   Lettieri, John T ^b   Heller, Allen H ^b   Polk, Ron E ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; CIPROFLOXACIN; PROTHROMBIN; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG METABOLISM; DRUG SAFETY; HUMAN; LIVER METABOLISM; MULTICENTER STUDY; NORMAL HUMAN; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL;

EID: 9044222481     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/22.2.251     Document Type: Article

References (26)

1. Gillum JG, Israel DS, Polk RE. Pharmacokinetic drug interactions with antimicrobial agents. Clin Pharmacokinet 1993;25:450-82.
2. Mott FE, Murphy S, Hunt V. Ciprofloxacin and warfarin [letter]. Ann Intern Med 1989;111:542-3.
3. Linville D III, Emory C, Graves L III. Ciprofloxacin and warfarin interaction [letter]. Am J Med 1991;90:765.
4. Dugoni-Kramer BM. Ciprofloxacin-warfarin interaction [letter]. Drug Intelligence and Clinical Pharmacy 1991;25:1397.
5. Kamada AK. Possible interaction between ciprofloxacin and warfarin. Drug Intelligence and Clinical Pharmacy 1990;24:27-8.
6. Renzi R, Finkbeiner S. Ciprofloxacin interaction with sodium warfarin: a potentially dangerous side effect. Am J Emerg Med 1991;9:551-2.
7. Johnson KC, Joe RH, Self TH. Drug interaction [letter]. J Fam Pract 1991;33:338.
8. Hoffbrand BI. Interaction of nalidixic acid and warfarin [letter]. Br Med J 1974;2:666.
9. Leor J, Levartowsky D, Sharon C. Interaction between nalidixic acid and warfarin [letter]. Ann Intern Med 1987;107:601.
10. Linville T, Matanin D. Norfloxacin and warfarin [letter]. Ann Intern Med 1989;110:751-2.
11. Leor J, Matetzki S. Ofloxacin and warfarin [letter]. Ann Intern Med 1988;109:761.
12. Baciewicz AM, Ashar BH, Locke TW. Interaction of ofloxacin and warfarin [letter]. Ann Intern Med 1993;119:1223.
13. Jolson HM, Tanner LA, Green L, Grasela TH Jr. Adverse reaction reporting of interaction between warfarin and fluoroquinolones. Arch Intern Med 1991;151:1003-4.
14. Wells PS, Holbrook AM, Crowther NR, Hirsh J. Interactions of warfarin with drugs and food. Ann Intern Med 1994;121:676-83.
15. Rocci ML Jr, Vlasses PH, Distlerath LM, et al. Norfloxacin does not alter warfarin's disposition or anticoagulant effect. J Clin Pharmacol 1990;30:728-32.
16. Toon S, Hopkins KJ, Garstang FM, Aarons L, Sedman A, Rowland M. Enoxacin-warfarin interaction: pharmacokinetic and stereochemical aspects. Clin Pharmacol Ther 1987;42:33-41.
17. Millar E, Coles S, Wyld P, Nimmo W. Temafloxacin does not potentiate the anticoagulant effect of warfarin in healthy subjects. Clin Pharmacokinet 1992;22(suppl 1):102-6.
18. Rindone JP, Kelly CL, Jones WN, Garewal HS, Keuey CL. Hypoprothrombinemic effect of warfarin not influenced by ciprofloxacin. Clin Pharm 1991;10:136-8.
19. Bianco TM, Bussey HI, Farnett LE, Linn WD, Roush MK, Wong YWJ. Potential warfarin-ciprofloxacin interaction in patients receiving long-term anticoagulation. Pharmacotherapy 1992;12:435-9.
20. Krol GJ, Noe AJ, Beermann D. Liquid chromatographic analysis of ciprofloxacin and ciprofloxacin metabolites in body fluids. Journal of Liquid Chromatography 1986;9:2897-919.
21. Sutfin T, Balmer K, Boström H, Eriksson S, Höglund P, Paulsen O. Stereo-selective interaction of omeprazole with warfarin in healthy men. Ther Drug Monit 1989;11:176-84.
22. General diagnostics operations manual. Durham, North Carolina: Organon Teknika, 1985.
23. Fuhr U, Strobl G, Manaut F, et al. Quinolone antibacterial agents: relationship between structure and in vitro inhibition of the human cytochrome P450 isoform CYPlA2. Mol Pharmacol 1993;43:191-9.
24. Rettie AE, Korzekwa KR, Kunze KL, et al. Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions. Chem Res Toxicol 1992;5:54-9.
25. Hewick DS, McEwen J. Plasma half-lives, plasma metabolites and anticoagulant efficacies of the enantiomers of warfarin in man. J Pharm Pharmacol 1973;25:458-65.
26. Soons PA, Grib C, Breimer DD, Kirch W. Effects of acute febrile infectious diseases on the oral pharmacokinetics and effects of nitrendipine enantiomers and of bisoprolol. Clin Pharmacokinet 1992;23:238-48.